Thursday, January 28, 2021
Home Authors Posts by Editor / Curator

Editor / Curator

383 POSTS 0 COMMENTS
HAPBEE
All News

Hapbee (HAPB): The Netflix of Feelings

Editor / Curator -
Aphex
CoronaVirus

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement...

Editor / Curator -
All News

Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

Editor / Curator -
BioSig, Biotech Stock Review
All News

BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems

Editor / Curator -
Dr. Marc Hellerstein
CoronaVirus

Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To...

Editor / Curator -
Biotech Stock Review, Fatty Liver
Biotech News

Fatty Liver? 15-25% of the US Population Has It. (Video)

Editor / Curator -
Kevin Harrington, Internet Stock Review
Superbug News - CoronaVirus Watch List

SinoFresh. One-Stop E-Commerce OTC Health & Wellness Pharmacy

Editor / Curator -
Biotech News

Hepion Pharma Doses First Patient in the ‘AMBITION’ Clinical Trial.

Editor / Curator -
Cyclophilin, Biotech Stock Review
Biotech News

Adding Hepion Pharma (HEPA) $1.73 to Watch List.

Editor / Curator -
1234...39Page 3 of 39

Latest article

Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

2020 Watch List Editor / Curator -
The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

2020 Watch List Editor / Curator -
Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

Video: Pacific Stem Cell

Stem Cells Editor / Curator -
With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.